Linear Therapies a joint venture of highly accomplished drug discovers and life science innovators utilizing an AI-powered, advanced drug discovery and development platform. Linear Therapies is using the breakthrough solubility technology to create new intellectual properties by formulating biologically active products into novel drugs with increased bioavailability. Linear Therapies is focusing on delivering a safe and immediate anti-pathogen specifically targeted at the COVID-19 pandemic. After accomplishing this primary objective, the company will expand the practice to address international threats including current and mutant-strains of SARS, MERS, Coronavirus, Ebola and natural and man-made threatening pathogens or bio-hazards.